A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis (Q40353912)

13 June 2018

title

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis (English)

1 reference

13 June 2018

author

Philip Seo

7

0 references

Carol A Langford

1

Carol A Langford

1 reference

13 June 2018

Curry Koening

10

Curry L Koening

1 reference

13 June 2018

Paul A Monach

5

Paul A Monach

1 reference

13 June 2018

Carol A McAlear

13

Carol A McAlear

1 reference

13 June 2018

Antoine G Sreih

11

Antoine G Sreih

1 reference

13 June 2018

Peter A Merkel

21

Peter A Merkel

1 reference

13 June 2018

Jeffrey P Krischer

20

Jeffrey P Krischer

1 reference

13 June 2018

David Cuthbertson

2

David Cuthbertson

1 reference

13 June 2018

Simon Carette

6

Simon Carette

1 reference

13 June 2018

Lindsy J Forbess

17

Lindsy J Forbess

1 reference

13 June 2018

Nader Khalidi

4

Nader Khalidi

1 reference

13 June 2018

Larry Moreland

8

Larry W Moreland

1 reference

13 June 2018

Steven Yariv

3

Steven R Ytterberg

1 reference

13 June 2018

Vasculitis Clinical Research Consortium

22

Vasculitis Clinical Research Consortium

1 reference

13 June 2018

Christian Pagnoux

15

Christian Pagnoux

1 reference

13 June 2018

Kenneth J Warrington

14

Kenneth J Warrington

1 reference

13 June 2018

Gary G Hoffman

18

Gary S Hoffman

1 reference

13 June 2018

Robert Spiera

12

Robert Spiera

1 reference

13 June 2018

Michael H Weisman

9

Michael Weisman

1 reference

13 June 2018

Kathleen McKinnon

16

Kathleen McKinnon

1 reference

13 June 2018

Renee Borchin

19

Renée Borchin

1 reference

13 June 2018

publication date

3 March 2017

1 reference

13 June 2018

published in

Arthritis & Rheumatology

1 reference

13 June 2018

volume

69

1 reference

13 June 2018

issue

4

1 reference

13 June 2018

page(s)

837-845

1 reference

13 June 2018

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Vascular dendritic cells in giant cell arteritis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Giant-cell arteritis and polymyalgia rheumatica

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Medium- and large-vessel vasculitis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Polymyalgia rheumatica and giant-cell arteritis.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Structural analysis of CTLA-4 function in vivo

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Giant Cell Vasculitis Is a T Cell-Dependent Disease

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Design of the tocilizumab in giant cell arteritis trial

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Giant cell arteritis as an antigen-driven disease.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Visual prognosis in giant cell arteritis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

CTLA4Ig: bridging the basic immunology with clinical application

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5378642

Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica

20 August 2018

1 reference

12 December 2020

A signal achievement in the treatment of arthritis

1 reference

12 December 2020

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

12 December 2020

Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.40044

1 reference

13 June 2018

PMC publication ID

5378642

1 reference

13 June 2018

PubMed publication ID

28133925

1 reference

13 June 2018